Investors & Media International Stem Cell Corporation to Present at LD Micro Conference April 29, 2008 International Stem Cell Corporation Announces Collaboration with the University of Cambridge to Study Parthenogenetic Stem Cells International Stem Cell Corporation Signs Letter of Intent with BioTime, Inc., and Embryome Sciences to Provide Unique Human Stem Cell Lines for Research Use International Stem Cell Corporation Announces Manufacturing and Supply Agreement With ATCC International Stem Cell Corporation's Human Parthenogenetic Stem Cells to be used in Germany in the Development of Treatments for Neural Disease International Stem Cell Corporation to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference February 19, 2008 International Stem Cell Corporation Chairman Adds CEO Role INTERNATIONAL STEM CELL CORPORATION CHAIRMAN KENNETH ALDRICH TO BE INTERVIEWED ON WALLST.NET International Stem Cell Corporation to Provide Corneal Epithelial Cells Differentiated from Its Parthenogenetic Stem Cells for Use in Photorefractive Keratectomy (PRK) FDA Clinical Trials Human Embryonic Stem Cell Lines Created That Avoid Immune Rejection in Large Segments of the Population 27 28 29 30 31 32 33 34 35 << < > >>
